ESSA Pharma Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q3 2019 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
ESSA Pharma Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q3 2019 to Q3 2024.
  • ESSA Pharma Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending September 30, 2024 was $50.3M, a 11.3% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $50.3M +$5.08M +11.3% Sep 30, 2024 10-K 2024-12-17
Q3 2023 $45.2M +$5M +12.5% Sep 30, 2023 10-K 2024-12-17
Q3 2022 $40.2M +$7.01M +21.1% Sep 30, 2022 10-K 2023-12-12
Q3 2021 $33.2M +$10.3M +45% Sep 30, 2021 10-K 2022-12-13
Q3 2020 $22.9M +$4.2M +22.5% Sep 30, 2020 10-K 2021-11-18
Q3 2019 $18.7M Sep 30, 2019 10-K 2020-12-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.